News

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million
The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol ...
Public Shell Firms Ramping Up Altcoin Buys Draws Skepticism: FT
Extending the BTC treasury plans to smaller altcoins has been described as "hugely speculative" and a "flash in the pan" ...